Home page

Booming TCM Exchanges Between China and Foreign Countries! French & South Korean Delegates Visit Jibaichuan to Explore New Big Health Industry Cooperation Prospects

Release date:

2026-07-17

In early July, delegations from France and South Korea in the field of traditional Chinese medicine (TCM) visited Zhejiang JibaiChuan Pharmaceutical one after another. They engaged in in-depth exchanges on topics including wild‑grown lingzhi mushrooms cultivated under forest canopies, the integration of industry, academia, and research in TCM, and the coordinated development of the international health‑care industry, using TCM as a bridge to establish a platform for mutual cultural learning and cross‑border industrial cooperation.

On July 9, a delegation led by Wu Wanlin, Chairman of the France–China Center for Traditional Chinese Medicine, paid a visit to JibaiChuan Pharmaceutical, touring the JibaiChuan Oriental Ganoderma Culture Museum and its standardized GMP‑compliant production facility.

Bao Jiajin, Chairman of JibaiChuan, conducted a thorough on-site assessment of the company’s R&D strategy and modern processing system, which integrate industry, academia, research, and clinical practice in the fields of lingzhi and other traditional Chinese medicinal materials. Chairman Wu Wanlin and his delegation expressed high praise for JibaiChuan’s model of cultivating authentic, eco‑friendly, regionally sourced medicinal herbs.

On July 13, the China–South Korea High-Quality Collaborative Development Exchange Conference kicked off in Jinhua.

Jiang Weili, General Manager of JibaiChuan Pharmaceutical, presented to the China–South Korea delegation on-site the pivotal role of wild‑cultivated lingzhi in traditional Chinese medicine, its practical applications in health and wellness, and the development potential of the wild‑cultivated lingzhi industry within the modern greater‑health sector.

The Korean delegation expressed keen interest in the wild‑cultivated, authentic lingzhi resources under forest canopies. Following the meeting, they made a special visit to the JibaiChuan Taxus chinensis–based lingzhi cultivation base, gaining first-hand insight into the eco‑friendly, under‑forest cultivation model for wild‑adapted lingzhi.

This series of international exchanges has deepened mutual trust in traditional Chinese medicine (TCM) cultures between China and other countries, broadened channels for complementary industrial cooperation and synergistic development, facilitated the implementation of cooperative initiatives, and laid a solid foundation for in-depth collaboration in the global health sector.

Looking ahead, JibaiChuan will leverage Pan’an’s abundant resources of Chinese medicinal herbs, continuously expand international channels for TCM exchange, and, using authentic wild‑cultivated lingzhi as its flagship product, further strengthen global collaboration within the greater health industry.